AI Hunt for ALS Treatment Continues With 28 Novel Targets Revealed by Insilico Medicine
Insilico Medicine identified 28 new targets for the treatment of amyotrophic lateral sclerosis (ALS) using its proprietary AI-driven platform PandaOmics. … Read More
